21825889

Source:http://linkedlifedata.com/resource/pubmed/id/21825889

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007113, umls-concept:C0017262, umls-concept:C0185117, umls-concept:C0387583, umls-concept:C0681890, umls-concept:C1280500, umls-concept:C1418946, umls-concept:C1516213, umls-concept:C1521733, umls-concept:C1550147, umls-concept:C2745888, umls-concept:C2911684
pubmed:issue	9
pubmed:dateCreated	2011-8-9
pubmed:abstractText	CD133 confers chemoradioresistance properties to cells and has recently been used to identify cancer-initiating cells.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21825889-21825883
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372764
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/AC133 antigen, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2, http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Tegafur, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/Uracil
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1530-0358
pubmed:author	pubmed-author:HaseKazuoK, pubmed-author:HashiguchiYojiroY, pubmed-author:IshiguroMegumiM, pubmed-author:KobayashiHirotoshiH, pubmed-author:MochizukiHidetakaH, pubmed-author:ShintoEijiE, pubmed-author:UenoHidekiH, pubmed-author:YamamotoJunjiJ
pubmed:issnType	Electronic
pubmed:volume	54
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1098-106
pubmed:meshHeading	pubmed-meshheading:21825889-Adult, pubmed-meshheading:21825889-Aged, pubmed-meshheading:21825889-Aged, 80 and over, pubmed-meshheading:21825889-Antigens, CD, pubmed-meshheading:21825889-Antimetabolites, Antineoplastic, pubmed-meshheading:21825889-Biopsy, pubmed-meshheading:21825889-Chi-Square Distribution, pubmed-meshheading:21825889-Colonoscopy, pubmed-meshheading:21825889-Cyclooxygenase 2, pubmed-meshheading:21825889-Female, pubmed-meshheading:21825889-Glycoproteins, pubmed-meshheading:21825889-Humans, pubmed-meshheading:21825889-Immunoenzyme Techniques, pubmed-meshheading:21825889-Logistic Models, pubmed-meshheading:21825889-Lymph Node Excision, pubmed-meshheading:21825889-Lymphatic Metastasis, pubmed-meshheading:21825889-Male, pubmed-meshheading:21825889-Middle Aged, pubmed-meshheading:21825889-Peptides, pubmed-meshheading:21825889-Predictive Value of Tests, pubmed-meshheading:21825889-Radiotherapy Dosage, pubmed-meshheading:21825889-Receptor, Epidermal Growth Factor, pubmed-meshheading:21825889-Rectal Neoplasms, pubmed-meshheading:21825889-Tegafur, pubmed-meshheading:21825889-Treatment Outcome, pubmed-meshheading:21825889-Tumor Markers, Biological, pubmed-meshheading:21825889-Uracil
pubmed:year	2011
pubmed:articleTitle	Pretreatment CD133 and cyclooxygenase-2 expression as the predictive markers of the pathological effect of chemoradiotherapy in rectal cancer patients.
pubmed:affiliation	Department of Surgery, National Defense Medical College, Saitama, Japan. eiji-c@zf6.so-net.ne.jp
pubmed:publicationType	Journal Article